The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Systemic Endothelin Receptor Blockade Decreases Peripheral Vascular Resistance and Blood Pressure in Humans
Abstract
Background Although local inhibition of the generation or actions of endothelin-1 has been shown to cause forearm vasodilatation, the systemic effects of endothelin receptor blockade in healthy humans are unknown. We therefore investigated the cardiovascular effects of a potent peptide endothelin ET A/B receptor antagonist, TAK-044, in healthy men. Methods and Results Two randomized, placebo-controlled, crossover studies were performed. In nine subjects, TAK-044 (10 to 1000 mg IV over a 15-minute period) caused sustained dose-dependent peripheral vasodilatation and hypotension. Four hours after infusion of the highest dose (1000 mg), there were decreases in mean arterial pressure of 18 mm Hg and total peripheral resistance of 665 AU and increases in heart rate of 8 bpm and cardiac index of 0.9 L·min−1·m−2 compared with placebo. TAK-044 caused a rapid, dose-dependent increase in plasma immunoreactive endothelin (from 3.3 to 35.7 pg/mL within 30 minutes after 1000 mg). In a second study in eight subjects, intravenous administration of TAK-044 at doses of 30, 250, and 750 mg also caused peripheral vasodilatation, and all three doses abolished local forearm vasoconstriction to brachial artery infusion of endothelin-1. Brachial artery infusion of TAK-044 caused local forearm vasodilatation. Conclusions The endothelin ET A/B receptor antagonist TAK-044 decreases peripheral vascular resistance and, to a lesser extent, blood pressure; increases circulating endothelin concentrations; and blocks forearm vasoconstriction to exogenous endothelin-1. These results suggest that endogenous generation of endothelin-1 plays a fundamental physiological role in maintenance of peripheral vascular tone and blood pressure. The vasodilator properties of endothelin receptor antagonists may prove valuable therapeutically.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A novel potent vasoconstrictor peptide produced by vascular endothelial cells
Yanagisawa, M., Kurihara, H., Kimura, S., Tomobe, Y., Kobayashi, M., Mitsui, Y., Yazaki, Y., Goto, K., & Masaki, T. (1988) · Nature · doi:10.1038/332411a0 · Cited by 10,729
Fundamentals of Biostatistics.
(1969) · Annals of Internal Medicine · doi:10.7326/0003-4819-70-4-873 · Cited by 4,575
Cloning and expression of a cDNA encoding an endothelin receptor
Arai, H., Hori, S., Aramori, I., Ohkubo, H., & Nakanishi, S. (1990) · Nature · doi:10.1038/348730a0 · Cited by 2,578
Inoue, A., Yanagisawa, M., Kimura, S., Kasuya, Y., Miyauchi, T., Goto, K., & Masaki, T. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.8.2863 · Cited by 2,517
Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor
Sakurai, T., Yanagisawa, M., Takuwat, Y., Miyazakit, H., Kimura, S., Goto, K., & Masaki, T. (1990) · Nature · doi:10.1038/348732a0 · Cited by 2,424
Xu, D., Emoto, N., Giaid, A., Slaughter, C., Kaw, S., deWit, D., & Yanagisawa, M. (1994) · Cell · doi:10.1016/0092-8674(94)90425-1 · Cited by 921
Biological profiles of highly potent novel endothelin antagonists selective for the ETA receptor
Ihara, M., Noguchi, K., Saeki, T., Fukuroda, T., Tsuchida, S., Kimura, S., Fukami, T., Ishikawa, K., Nishikibe, M., & Yano, M. (1992) · Life Sciences · doi:10.1016/0024-3205(92)90331-i · Cited by 869
Clearance of Circulating Endothelin-1 by ETB Receptors in Rats
Fukuroda, T., Fujikawa, T., Ozaki, S., Ishikawa, K., Yano, M., & Nishikibe, M. (1994) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1994.1395 · Cited by 625
Contribution of endogenous generation of endothelin-1 to basal vascular tone
HAYNES, W. (1994) · The Lancet · doi:10.1016/s0140-6736(94)92827-4 · Cited by 591
Self-citationClozel, M., Breu, V., Burri, K., Cassal, J.-M., Fischli, W., Gray, G. A., Hirth, G., Löffier, B.-M., Müller, M., Neidhart, W., et al. (1993) · Nature · doi:10.1038/365759a0 · Cited by 518
Both ETA and ETB receptors mediate contraction to endothelin-1 in human blood vessels.
Seo, B., Oemar, B. S., Siebenmann, R., von Segesser, L., & Lüscher, T. F. (1994) · Circulation · doi:10.1161/01.cir.89.3.1203 · Cited by 517
Measuring Forearm Blood Flow and Interpreting the Responses to Drugs and Mediators
Benjamin, N., Calver, A., Collier, J., Robinson, B., Vallance, P., & Webb, D. (1995) · Hypertension · doi:10.1161/01.hyp.25.5.918 · Cited by 399
Self-citationHaynes, W. G., Strachan, F. E., & Webb, D. J. (1995) · Circulation · doi:10.1161/01.cir.92.3.357 · Cited by 279
Self-citationToyo-oka, T., Aizawa, T., Suzuki, N., Hirata, Y., Miyauchi, T., Shin, W. S., Yanagisawa, M., Masaki, T., & Sugimoto, T. (1991) · Circulation · doi:10.1161/01.cir.83.2.476 · Cited by 246
Endothelin in myocardial infarction
WATANABE, T., SUZUKI, N., SHIMAMOTO, N., FUJINO, M., & IMADA, A. (1990) · Nature · doi:10.1038/344114a0 · Cited by 177
Appel, P. L., Kram, H. B., Mackabee, J. R., Fleming, A. W., & Shoemaker, W. C. (1986) · Critical Care Medicine · doi:10.1097/00003246-198611000-00004 · Cited by 156
Evidence for endothelin-induced renal vasoconstriction independent of ETA receptor activation
Pollock, D. M., & Opgenorth, T. J. (1993) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1993.264.1.r222 · Cited by 138
Davenport, A. P., O'Reilly, G., Molenaar, P., Maguire, J. J., Kuc, R. E., Sharkey, A., Bacon, C. R., & Ferro, A. (1993) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199322008-00008 · Cited by 133
Northridge, D. B., Findlay, I. N., Wilson, J. T., Henderson, E., & Dargie, H. J. (1990) · Heart · doi:10.1136/hrt.63.2.93 · Cited by 121
Benjamin, N., Cockcroft, J. R., Collier, J., Dollery, C. T., Ritter, J. M., & Webb, D. J. (1989) · The Journal of Physiology · doi:10.1113/jphysiol.1989.sp017630 · Cited by 103
Self-citationHaynes, W. G., Hand, M. F., Johnstone, H. A., Padfield, P. L., & Webb, D. J. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117470 · Cited by 102
Self-citationThomas, S. H. L. (1992) · PubMed Central · Cited by 80
Wieczorek, I., Haynes, W. G., Webb, D. J., Ludlam, C. A., & Fox, K. A. A. (1994) · Heart · doi:10.1136/hrt.72.5.436 · Cited by 79
Self-citationWarner, T. D., Allcock, G. H., & Vane, J. R. (1994) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1994.tb13053.x · Cited by 61
L-NMMA Increases blood pressure in man
Haynes, W. G., Noon, J. P., Walker, B. R., & Webb, D. J. (1993) · The Lancet · doi:10.1016/0140-6736(93)91981-q · Cited by 61
Self-citationGardiner, S. M., Kemp, P. A., March, J. E., & Bennett, T. M. (1994) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1994.tb13153.x · Cited by 43
Cited by
Davenport, A. P., Hyndman, K. A., Dhaun, N., Southan, C., Kohan, D. E., Pollock, J. S., Pollock, D. M., Webb, D. J., & Maguire, J. J. (2016) · Pharmacological Reviews · doi:10.1124/pr.115.011833 · Cited by 772
Self-citationEndothelin System: The Double-Edged Sword in Health and Disease
Kedzierski, R. M., & Yanagisawa, M. (2001) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.41.1.851 · Cited by 745
PATHOPHYSIOLOGY OF ENDOTHELIN IN THE CARDIOVASCULAR SYSTEM
Miyauchi, T., & Masaki, T. (1999) · Annual Review of Physiology · doi:10.1146/annurev.physiol.61.1.391 · Cited by 544
The endothelin system in pulmonary arterial hypertension
GALIE, N. (2004) · Cardiovascular Research · doi:10.1016/j.cardiores.2003.11.026 · Cited by 515
Verhaar, M. C., Strachan, F. E., Newby, D. E., Cruden, N. L., Koomans, H. A., Rabelink, T. J., & Webb, D. J. (1998) · Circulation · doi:10.1161/01.cir.97.8.752 · Cited by 453
Self-citation
Metadata
- Authors
- Haynes, W. G., Ferro, C. J., O’Kane, K. P. J., Somerville, D., Lomax, C. C., & Webb, D. J.
- Venue
- Circulation
- Published
- 1996-05-15
- Volume
- 93
- Issue
- 10
- Pages
- 1860-1870
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2020741324
- Cited by
- 318
- References
- 26
- FWCI
- 21.84
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.